SI0866876T1 - Process for the preparation of recombinant proteins in e.coli by high cell density fermentation - Google Patents

Process for the preparation of recombinant proteins in e.coli by high cell density fermentation

Info

Publication number
SI0866876T1
SI0866876T1 SI9630466T SI9630466T SI0866876T1 SI 0866876 T1 SI0866876 T1 SI 0866876T1 SI 9630466 T SI9630466 T SI 9630466T SI 9630466 T SI9630466 T SI 9630466T SI 0866876 T1 SI0866876 T1 SI 0866876T1
Authority
SI
Slovenia
Prior art keywords
coli
preparation
cell density
recombinant proteins
high cell
Prior art date
Application number
SI9630466T
Other languages
English (en)
Slovenian (sl)
Inventor
Wolfgang Strittmatter
Siegfried Matzku
Dieter Riesenberg
Uwe Horn
Uwe KN�PFER
Marian Kujau
Rolf Wenderoth
Andreas PL�CKTHUN
Anke Krebber
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SI0866876T1 publication Critical patent/SI0866876T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SI9630466T 1995-12-11 1996-11-28 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation SI0866876T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95119478 1995-12-11
EP96941047A EP0866876B1 (de) 1995-12-11 1996-11-28 Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation
PCT/EP1996/005260 WO1997021829A1 (de) 1995-12-11 1996-11-28 Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation

Publications (1)

Publication Number Publication Date
SI0866876T1 true SI0866876T1 (en) 2002-08-31

Family

ID=8219878

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630466T SI0866876T1 (en) 1995-12-11 1996-11-28 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation

Country Status (24)

Country Link
US (1) US6410270B1 (pl)
EP (1) EP0866876B1 (pl)
JP (2) JP4101879B2 (pl)
KR (1) KR100444735B1 (pl)
CN (1) CN1117160C (pl)
AR (1) AR005035A1 (pl)
AT (1) ATE213271T1 (pl)
AU (1) AU716612B2 (pl)
BR (1) BR9611937A (pl)
CA (1) CA2240097C (pl)
CZ (1) CZ291415B6 (pl)
DE (1) DE59608743D1 (pl)
DK (1) DK0866876T3 (pl)
ES (1) ES2171752T3 (pl)
HU (1) HU227945B1 (pl)
NO (1) NO319090B1 (pl)
PL (1) PL185665B1 (pl)
PT (1) PT866876E (pl)
RU (1) RU2201455C2 (pl)
SI (1) SI0866876T1 (pl)
SK (1) SK283169B6 (pl)
UA (1) UA61066C2 (pl)
WO (1) WO1997021829A1 (pl)
ZA (1) ZA9610384B (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
AU1223600A (en) 1998-10-28 2000-05-15 Genentech Inc. Process
ES2324645T3 (es) 2000-11-03 2009-08-12 Genentech, Inc. Cambios de tasa metabolica en fermentaciones que expresen proteinas recombinantes.
ATE416260T1 (de) * 2001-07-06 2008-12-15 Merck Patent Gmbh Verfahren zur überwachung und modulierung von proteinfaltung
JP2007530013A (ja) * 2003-12-12 2007-11-01 コンジュゴン インコーポレーティッド 緻密に調節された遺伝子発現のためのシステム
WO2005066340A1 (en) * 2003-12-23 2005-07-21 Council Of Scientific And Industrial Research Process for producing streptokinase using genetically modified escherichia coli
KR20070100307A (ko) * 2004-12-22 2007-10-10 제넨테크, 인크. 가용성 다중 막관통 단백질의 생산 방법
CN105463045A (zh) * 2006-07-27 2016-04-06 惠氏公司 用于生产重组蛋白质的高细胞密度补料-分批发酵方法
RU2518289C2 (ru) 2006-09-13 2014-06-10 Эббви Инк, Способ получения антитела или его фрагмента с подпиткой (варианты)
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
KR20110056323A (ko) 2008-09-15 2011-05-26 제넨테크, 인크. 세포 오스몰농도를 조절하기 위한 조성물 및 방법
BR112012001917B1 (pt) * 2009-07-28 2018-10-16 Mitsui Chemicals Inc método para produzir ácido láctico
EP2532734B1 (en) * 2010-02-01 2017-03-15 Proyecto de Biomedicina CIMA, S.L. Process for the production of interferon alpha 5
JP5798193B2 (ja) * 2010-08-30 2015-10-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ アルカリ性フィード
KR101252150B1 (ko) * 2010-11-18 2013-04-08 한국과학기술원 재조합 ＤＮＡ 분자 클로닝을 위한 알데히드 환원효소 ＹｑｈＤ 유전자를 포함하는 자살 벡터
RU2507736C2 (ru) * 2011-01-11 2014-02-27 Федеральное государственное бюджетное учреждение науки Институт биологии гена Российской академии наук (ИБГ РАН) Способ создания трансгенных растений с высоким уровнем экспрессии трансгенного белка
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
RU2496877C2 (ru) * 2011-12-15 2013-10-27 Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") ПЛАЗМИДНЫЙ ВЕКТОР pHYP С ПОВЫШЕННОЙ СЕГРЕГАЦИОННОЙ СТАБИЛЬНОСТЬЮ ДЛЯ ЭКСПРЕССИИ РЕКОМБИНАНТНОГО БЕЛКА, БАКТЕРИЯ - ПРОДУЦЕНТ ПРЕДШЕСТВЕННИКА РЕКОМБИНАНТНОГО БЕЛКА И СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО БЕЛКА
AU2013224027B2 (en) 2012-02-23 2019-01-24 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
DK2825633T3 (da) 2012-03-12 2019-05-20 Hanmi Science Co Ltd Fremgangsmåde til dyrkning af E. coli-celler til høj densitet
CN102604904B (zh) * 2012-03-14 2013-09-18 苏州汉酶生物技术有限公司 一种葡萄糖脱氢酶的生产方法
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
CA2883272A1 (en) 2012-09-02 2014-03-06 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CN105377874A (zh) 2013-03-08 2016-03-02 建新公司 治疗性蛋白药物物质的整合连续制造
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
US9714273B2 (en) * 2014-10-08 2017-07-25 Utah State University Expression systems and associated methods
RU2021134624A (ru) 2015-10-22 2022-03-15 Джуно Терапьютикс Гмбх Способы, наборы, средства и устройства для трансдукции
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
CN110684101A (zh) * 2019-11-15 2020-01-14 上海松皓生物科技有限公司 一种重组水蛭素的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558864A (en) 1991-03-06 1996-09-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies

Also Published As

Publication number Publication date
EP0866876B1 (de) 2002-02-13
DK0866876T3 (da) 2002-05-27
CN1117160C (zh) 2003-08-06
SK283169B6 (sk) 2003-03-04
DE59608743D1 (de) 2002-03-21
ZA9610384B (en) 1997-06-23
AU1032597A (en) 1997-07-03
RU2201455C2 (ru) 2003-03-27
NO982672L (no) 1998-06-10
SK74098A3 (en) 1998-11-04
WO1997021829A1 (de) 1997-06-19
HU227945B1 (en) 2012-06-28
PT866876E (pt) 2002-07-31
HUP0000317A2 (hu) 2000-06-28
AU716612B2 (en) 2000-03-02
BR9611937A (pt) 1999-03-02
AR005035A1 (es) 1999-04-07
CN1219203A (zh) 1999-06-09
KR19990072037A (ko) 1999-09-27
US6410270B1 (en) 2002-06-25
JP2000501936A (ja) 2000-02-22
KR100444735B1 (ko) 2004-11-10
JP2007185197A (ja) 2007-07-26
EP0866876A1 (de) 1998-09-30
ES2171752T3 (es) 2002-09-16
CZ165298A3 (cs) 1998-08-12
CA2240097C (en) 2005-07-26
ATE213271T1 (de) 2002-02-15
JP4102422B2 (ja) 2008-06-18
CZ291415B6 (cs) 2003-03-12
NO319090B1 (no) 2005-06-20
JP4101879B2 (ja) 2008-06-18
NO982672D0 (no) 1998-06-10
PL185665B1 (pl) 2003-06-30
PL327188A1 (en) 1998-11-23
HUP0000317A3 (en) 2001-09-28
UA61066C2 (en) 2003-11-17
CA2240097A1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
HUP0000317A3 (en) Process for the preparation of recombinant proteins in e.coli by high cell density fermentation
HUP9800901A3 (en) Process, medium and cell culture system for the preparation of recombinant factor viii in a protein free medium
ZA964776B (en) Mammalian cell culture process.
AU650909B2 (en) Process for introducing foreign DNA into cell
AU2455295A (en) Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
GB9614700D0 (en) Over-expression of proteins in E.Coli
AU7762691A (en) Process for producing protein
CA2306449A1 (en) Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
AU1322692A (en) Method for the in vitro production of protein from a dna sequence without cloning
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
AU3866197A (en) Novel DNA and process for preparing protein using the DNA
AU2667995A (en) Chimerical peptide-nucleic acid fragment, process for producing the same and its use for appropriately introducing nucleic acids into cell organelles and cells
EP0816510A4 (en) PROCESS FOR PRODUCING BIOLOGICALLY ACTIVE FUSED PROTEINS
AU676277B2 (en) DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
AU3823795A (en) Novel mammalian protein associated with uncontrolled cell division
EP0706562A4 (en) CULTURE MEDIUM FOR RECOMBINANT YEAST
AU3608589A (en) Expression vectors for the preparation of infused proteins in microorganisms
AU7193296A (en) Process for the ultrafiltration of biological matrices comprising peptides or proteins
EP1144611A3 (en) Method for recombinant protein production in mammalian cells comprising co-expression with fetuin
AU5309586A (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms
WO1991010721A3 (de) Verfahren zur hochzelldichte-fermentation von escherichia coli in einem rührkesselfermentor
AU6756396A (en) Heterologous protein production system using avian cells
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
LTIP1543A (en) Process for enzymatic decomposition of recombinant proteins by means of iga-protease, fused protein, recombinant dna, cell
AU4971090A (en) Eimeria membrane associated protein immunogens